Tygh Capital Management, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$4,278,000
+6.9%
64,518
+0.6%
0.55%
+0.9%
Q3 2021$4,003,000
-23.6%
64,127
+1.4%
0.54%
-24.1%
Q2 2021$5,240,000
+23.6%
63,269
-1.1%
0.71%
+19.2%
Q1 2021$4,240,000
-36.1%
63,947
-26.1%
0.60%
-42.0%
Q4 2020$6,638,000
+176.6%
86,512
+55.2%
1.03%
+127.0%
Q3 2020$2,400,00055,7260.46%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders